LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)
CNY 7.25
(-0.82%)
CNY 7.25
(-0.82%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.16 Billion CNY | 14.12% |
| 2022 | 1.01 Billion CNY | 24.65% |
| 2021 | 817.64 Million CNY | 22.39% |
| 2020 | 668.05 Million CNY | 6.24% |
| 2019 | 628.81 Million CNY | 15.47% |
| 2018 | 544.58 Million CNY | 8.67% |
| 2017 | 501.13 Million CNY | 37.96% |
| 2016 | 363.25 Million CNY | 10.89% |
| 2015 | 327.58 Million CNY | -17.91% |
| 2014 | 399.07 Million CNY | 36.89% |
| 2013 | 291.52 Million CNY | 9.45% |
| 2012 | 266.36 Million CNY | -1.78% |
| 2011 | 271.18 Million CNY | 3.35% |
| 2010 | 262.4 Million CNY | 13.0% |
| 2009 | 232.2 Million CNY | 6.03% |
| 2008 | 219.01 Million CNY | 23.39% |
| 2007 | 177.48 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 221.55 Million CNY | -19.24% |
| 2024 Q3 | 209.65 Million CNY | -5.37% |
| 2024 Q1 | 274.32 Million CNY | -9.35% |
| 2023 Q4 | 302.62 Million CNY | 20.34% |
| 2023 FY | 1.16 Billion CNY | 14.12% |
| 2023 Q3 | 251.47 Million CNY | -16.63% |
| 2023 Q1 | 307.39 Million CNY | -4.17% |
| 2023 Q2 | 301.63 Million CNY | -1.87% |
| 2022 Q4 | 320.76 Million CNY | 35.56% |
| 2022 Q3 | 236.62 Million CNY | 5.21% |
| 2022 FY | 1.01 Billion CNY | 24.65% |
| 2022 Q2 | 224.9 Million CNY | -5.05% |
| 2022 Q1 | 236.87 Million CNY | 54.35% |
| 2021 Q2 | 209.39 Million CNY | 18.01% |
| 2021 Q4 | 153.47 Million CNY | -44.66% |
| 2021 FY | 817.64 Million CNY | 22.39% |
| 2021 Q1 | 177.43 Million CNY | 7.05% |
| 2021 Q3 | 277.34 Million CNY | 32.45% |
| 2020 Q3 | 173.81 Million CNY | -8.77% |
| 2020 Q1 | 137.96 Million CNY | -14.46% |
| 2020 FY | 668.05 Million CNY | 6.24% |
| 2020 Q4 | 165.74 Million CNY | -4.64% |
| 2020 Q2 | 190.52 Million CNY | 38.1% |
| 2019 Q2 | 155.63 Million CNY | -0.26% |
| 2019 Q4 | 161.28 Million CNY | 3.47% |
| 2019 FY | 628.81 Million CNY | 15.47% |
| 2019 Q1 | 156.03 Million CNY | 11.54% |
| 2019 Q3 | 155.86 Million CNY | 0.15% |
| 2018 Q2 | 130.52 Million CNY | -8.61% |
| 2018 FY | 544.58 Million CNY | 8.67% |
| 2018 Q4 | 139.89 Million CNY | 6.53% |
| 2018 Q3 | 131.32 Million CNY | 0.61% |
| 2018 Q1 | 142.83 Million CNY | -18.9% |
| 2017 FY | 501.13 Million CNY | 37.96% |
| 2017 Q3 | 102.75 Million CNY | -15.27% |
| 2017 Q4 | 176.1 Million CNY | 71.38% |
| 2017 Q2 | 121.27 Million CNY | 20.08% |
| 2017 Q1 | 100.99 Million CNY | 6.11% |
| 2016 Q4 | 95.18 Million CNY | 9.09% |
| 2016 Q1 | 87.08 Million CNY | 25.85% |
| 2016 Q2 | 93.73 Million CNY | 7.64% |
| 2016 FY | 363.25 Million CNY | 10.89% |
| 2016 Q3 | 87.24 Million CNY | -6.92% |
| 2015 Q4 | 69.19 Million CNY | -26.88% |
| 2015 Q3 | 94.63 Million CNY | 7.24% |
| 2015 Q2 | 88.24 Million CNY | 16.85% |
| 2015 Q1 | 75.51 Million CNY | -0.08% |
| 2015 FY | 327.58 Million CNY | -17.91% |
| 2014 Q4 | 75.57 Million CNY | -29.39% |
| 2014 Q3 | 107.03 Million CNY | -5.5% |
| 2014 Q2 | 113.25 Million CNY | 9.74% |
| 2014 Q1 | 103.2 Million CNY | 71.27% |
| 2014 FY | 399.07 Million CNY | 36.89% |
| 2013 Q3 | 80.8 Million CNY | 7.43% |
| 2013 Q1 | 75.25 Million CNY | 42.98% |
| 2013 Q4 | 60.25 Million CNY | -25.42% |
| 2013 FY | 291.52 Million CNY | 9.45% |
| 2013 Q2 | 75.21 Million CNY | -0.06% |
| 2012 Q1 | 63.39 Million CNY | 57.91% |
| 2012 Q2 | 70.51 Million CNY | 11.23% |
| 2012 Q3 | 79.81 Million CNY | 13.18% |
| 2012 FY | 266.36 Million CNY | -1.78% |
| 2012 Q4 | 52.63 Million CNY | -34.05% |
| 2011 FY | 271.18 Million CNY | 3.35% |
| 2011 Q4 | 40.14 Million CNY | -61.73% |
| 2011 Q3 | 104.89 Million CNY | 65.35% |
| 2011 Q2 | 63.43 Million CNY | 1.18% |
| 2011 Q1 | 62.69 Million CNY | -10.21% |
| 2010 Q3 | 88.62 Million CNY | 0.0% |
| 2010 Q4 | 69.82 Million CNY | -21.21% |
| 2010 FY | 262.4 Million CNY | 13.0% |
| 2009 FY | 232.2 Million CNY | 6.03% |
| 2008 FY | 219.01 Million CNY | 23.39% |
| 2007 FY | 177.48 Million CNY | 0.0% |